Armata Pharmaceuticals (ARMP) Cash & Equivalents: 2013-2018
Historic Cash & Equivalents for Armata Pharmaceuticals (ARMP) over the last 6 years, with Sep 2018 value amounting to $13.4 million.
- Armata Pharmaceuticals' Cash & Equivalents rose 73.37% to $13.4 million in Q3 2018 from the same period last year, while for Sep 2018 it was $13.4 million, marking a year-over-year increase of 73.37%. This contributed to the annual value of $5.1 million for FY2017, which is negligibly% changed negligibly from last year.
- According to the latest figures from Q3 2018, Armata Pharmaceuticals' Cash & Equivalents is $13.4 million, which was down 13.17% from $15.4 million recorded in Q2 2018.
- Armata Pharmaceuticals' Cash & Equivalents' 5-year high stood at $16.6 million during Q1 2015, with a 5-year trough of $2.2 million in Q1 2017.
- Over the past 3 years, Armata Pharmaceuticals' median Cash & Equivalents value was $7.1 million (recorded in 2016), while the average stood at $7.6 million.
- Over the last 5 years, Armata Pharmaceuticals' Cash & Equivalents had its largest YoY gain of 2,185.81% in 2014, and its largest YoY loss of 67.67% in 2014.
- Armata Pharmaceuticals' Cash & Equivalents (Quarterly) stood at $6.6 million in 2014, then soared by 42.38% to $9.4 million in 2015, then slumped by 45.23% to $5.1 million in 2016, then remained steady at $5.1 million in 2017, then surged by 73.37% to $13.4 million in 2018.
- Its last three reported values are $13.4 million in Q3 2018, $15.4 million for Q2 2018, and $8.2 million during Q1 2018.